Arsenian-Henriksson Lab

Check out our recent review on Neuroblastoma, in which we discuss the cell of origin, current treatment protocols, and the precision medicine strategies under development, including metabolism, induction of differentiation, and immunotherapy. academic.oup.com/neuro-oncology…

Reflecting on the Stockholm MYC Conference we hosted at @karolinskainst a few weeks ago. Amazing talks, discussions, and shared insights will pave the way for advancements in MYC biology and treatment. #MYCResearch

A druggable conformational switch in the c-MYC transactivation domain nature.com/articles/s4146…

Available postdoc position in our lab ki.varbi.com/en/what:job/jo…

Our latest publication by Sainero-Alcolado et al Targeting MYC induces lipid droplet accumulation by upregulation of HILPDA in clear cell renal cell carcinoma pnas.org/doi/10.1073/pn…

Available postdoc position in our lab Postdoctoral studies in uncovering novel metabolic targets and differentiation inducing agents in tumors (scholarship) ki.varbi.com/en/what:job/jo…

Do you want to contribute to top quality medical research? 🔬 We are offering a postdoctoral position in identification of novel metabolic targets and differentiation inducing agents in cancer.🧬 ki.varbi.com/en/what:job/jo…

Do you want to contribute to top quality medical research? 🔬 We are offering a postdoctoral position in generation of a novel mouse model for neuroblastoma based on human induced pluripotent stem (iPS) cells.🧫 ki.varbi.com/en/what:job/jo…

In this review, Marie Arsenian Henriksson and colleagues discuss the potential of mitochondria as a target for precision medicine in cancer, presenting current inhibitors and challenges, and highlighting those enzymes that are attractive targets. #MTCPubs nature.com/articles/s4141…

Marie Arsenian-Henriksson and colleagues show that a combination therapy that activates three nuclear hormone receptors (GR, ERα and RARα) leads to neural differentiation, metabolic reprogramming and reduced tumour burden in neuroblastoma #MTCPubs jeccr.biomedcentral.com/articles/10.11…

Our paper is out! @karolinskainst @JournalofExper1